Effectiveness and Costs of Enhanced Cocaine Treatments

The study will evaluate the effectiveness, economic benefits, and costs of voucher reinforcement for cocaine and alcohol abstinence, additional counseling services, and their combination in a sample of cocaine dependent patients receiving outpatient treatment as usual in a community clinic.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine Dependence Chemically-Induced Disorders Cocaine-Related Disorders Mental Disorders Substance-Related Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Enrollment in an intensive outpatient program (IOP) for no more than 1 month
Current DSM-IV diagnosis of cocaine dependence (month prior to IOP treatment)
18-65 years of age
Ability to provide names of informants to help locate subject for follow-up

Exclusion criteria

IV heroin use in last year
Acute medical/psychiatric diagnosis that precludes outpatient treatment
Inpatient treatment for 6 weeks or more prior to IOP treatment
Incarceration for 6 months or more prior to IOP treatment

Treatment and study plan

Voucher Reinforcement

Behavioral

Extra Counseling Services

Behavioral

Voucher Reinforcement + Extra Counseling Services

Behavioral

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Registry information

Important dates

Study completion: 2007
First posted: Sep 14, 2005
Registry last updated: Dec 15, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed